Thousand Oaks city manager’s firing won’t hinder economy
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Amgen partnering with Japanese company to develop biosimilars
Thousand Oaks-based biotech giant Amgen said July 13 it will partner with a Japanese company to develop and commercialize biosimilars in Japan. Under the partnership, Amgen will develop and manufacture biosimilars while Daiichi Sankyo will obtain marketing approval, distribution and commercialization rights in Japan for the products. The deal also includes several late-stage development drugs. Read More →
Read More →California Lutheran University to launch nonprofit leadership center
Story updated at 11:45 a.m. on July 14: California Lutheran University has tapped a former Ventura County Community Foundation executive to start a nonprofit leadership center that aims to help fill the void created by the VCCF’s Center for Nonprofit Leadership closure. The Thousand Oaks-based university is launching a Center for Nonprofit Leadership in September Read More →
Read More →More residential units approved for Thousand Oaks Boulevard
The Thousand Oaks City Council unanimously approved on July 12 an amendment to a 2011 plan that allows the addition of 206 residential units on Thousand Oaks Boulevard. More than 26 people spoke during about two hours of debate about the amendment and 42 more wrote letters in support. The proposal will allow the development Read More →
Read More →Thousand Oaks names interim city manager
The Thousand Oaks City Council chose Assistant City Manager Andrew Powers to be interim city manager July 12. Former City Manager Scott Mitnick was fired July 7 after using his work email address to solicit donations for his sons’ high school baseball team. The council voted 5-0 to put Powers in charge while a search is conducted for a Read More →
Read More →FDA OKs wearable injector for Amgen’s Repatha cholesterol drug
The U.S. Food and Drug Administration approved a new type of injector for Amgen’s cholesterol reducing drug Repatha on July 11. The FDA approved a wearable injector, called the “Pushtronex” system, that sticks to patients’ bodies and delivers a dose of the drug monthly under the skin. Patients can perform moderate physical activities like walking Read More →
Read More →Embracing sustainability worth time, effort
By Valeria Makarova Conversations about the role of sustainability in a business organization can become heated. There are many supporters, but a number of skeptics as well. There is no argument that excessive use of hazardous materials, waste generated from production and consumption, and polluted land, air and ocean require proper attention and better management. Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
